AMG National Trust Bank’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-5,684
Closed -$1.17M – 447
2024
Q2
$1.17M Buy
5,684
+32
+0.6% +$7.25K 0.03% 275
2024
Q1
$1.53M Sell
5,652
-2
-0% -$478 0.04% 222
2023
Q4
$1.34M Sell
5,654
-55
-1% -$10.8K 0.04% 240
2023
Q3
$1.12M Buy
+5,709
New +$1.17M 0.04% 260

Other funds holding CRL

AMG National Trust Bank's CRL Position: Q3 2024 in Review

AMG National Trust Bank sold out of Charles River Laboratories (CRL) in Q3 2024, closing a stake of 5,684 shares — an estimated $1.17M sold.

AMG National Trust Bank first reported a position in CRL in Q3 2023 and held it in 4 quarters. The position peaked at $1.53M in Q1 2024. 628 funds tracked by Wall St. Rank hold CRL as of Q3 2024.

  • AMG National Trust Bank reported no remaining Charles River Laboratories position as of Q3 2024 after selling out during the quarter.
  • AMG National Trust Bank sold 5,684 Charles River Laboratories shares in Q3 2024, an estimated $1.17M.
  • AMG National Trust Bank first reported a position in Charles River Laboratories in Q3 2023 and held it in 4 quarters.
  • AMG National Trust Bank's Charles River Laboratories position peaked at $1.53M in Q1 2024.
  • 628 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2024.

Based on AMG National Trust Bank's 13F filing for Q3 2024, filed 7 Nov 2024.